黄色肉芽肿性胆囊炎的诊治

摘要/Abstract

中图分类号:

吴文韬, 李炜, 曹亦军. 黄色肉芽肿性胆囊炎的诊治[J]. 外科理论与实践, 2021, 26(03): 271-274.

WU Wenta, LI Wei, CAO Yijun. Diagnosis and treatment of xanthogranulomatous cholecystitis[J]. Journal of Surgery Concepts & Practice, 2021, 26(03): 271-274.

参考文献17

[18]	Zhao F, Lu PX, Yan SX, et al. CT and MR features of xanthogranulomatous cholecystitis: an analysis of conse-cutive 49 cases[J]. Eur J Radiol, 2013, 82(9):1391-1397. doi:10.1016/j.ejrad.2013.04.026 URL
[19]	Chun KA, Ha HK, Yu ES, et al. Xanthogranulomatous cholecystitis: CT features with emphasis on differentiation from gallbladder carcinoma[J]. Radiology, 1997, 203(1):93-97. pmid:9122422
[20]	Ogawa T, Horaguchi J, Fujita N, et al. High b-value diffusion-weighted magnetic resonance imaging for gallbladder lesions: differentiation between benignity and malignancy[J]. J Gastroenterol, 2012, 47(12):1352-1360. doi:10.1007/s00535-012-0604-1 URL
[21]	Shuto R, Kiyosue H, Komatsu E, et al. CT and MR ima-ging findings of xanthogranulomatous cholecystitis: corre-lation with pathologic findings[J]. Eur Radiol, 2004, 14(3):440-446. doi:10.1007/s00330-003-1931-7 URL
[22]	Kang TW, Kim SH, Park HJ, et al. Differentiating xanthogranulomatous cholecystitis from wall-thickening type of gallbladder cancer: added value of diffusion-weighted MRI[J]. Clin Radiol, 2013, 68(10):992-1001. doi:10.1016/j.crad.2013.03.022pmid:23622795
[23]	Koh T, Tanigichi H, Yamaguchi A, et al. Differential dia-gnosis of gallbladder cancer using positron emission tomography with fluorine-18-labeled fluoro-deoxyglucose(FDG-PET)[J]. J Surg Oncol, 2003, 84(2):74-81. doi:10.1002/jso.10295 URL
[24]	Anderson CD, Rice MH, Pinson CW, et al. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma[J]. J Gastrointest Surg, 2004, 8(1):90-97. doi:10.1016/j.gassur.2003.10.003 URL
[25]	李勇, 李凯琅, 曹葆强. 糖类抗原19-9在三种胆囊良恶性疾病中的表达研究[J]. 安徽医药, 2016, 20(10):1926-1929.
[26]	Yu H, Yu TN, Cai XJ. Tumor biomarkers: help or mislead in the diagnosis of xanthogranulomatous cholecystitis?-analysis of serum CA 19-9, carcinoembryonic antigen, and CA 12-5[J]. Chin Med J, 2013, 126(16):3044-3047.
[27]	Suzuki H, Wada S, Araki K, et al. Xanthogranulomatous cholecystitis: difficulty in differentiating from gallbladder cancer[J]. World J Gastroenterol, 2015, 21(35):10166-10173. doi:10.3748/wjg.v21.i35.10166 URL
[28]	张道建, 张德祥, 王吉文, 等. 超声造影对胆囊癌与黄色肉芽肿性胆囊炎的鉴别诊断价值[J]. 外科理论与实践, 2020, 25(4):322-325.
[29]	Hijioka S, Mekky M A, Bhatia V, et al. Can EUS-guided FNA distinguish between gallbladder cancer and xanthogranulomatous cholecystitis?[J]. Gastrointest Endosc, 2010, 72(3):622-627. doi:10.1016/j.gie.2010.05.022pmid:20630515
[30]	Krishnani N, Shukla S, Jain M, et al. Fine needle aspiration cytology in xanthogranulomatous cholecystitis, gallbladder adenocarcinoma and coexistent lesions[J]. Acta Cytol, 2000, 44(4):508-514. pmid:10934941
[31]	沈军, 董谦, 杨勇, 等. 黄色肉芽肿性胆囊炎的临床诊断及治疗[J]. 中国普通外科杂志, 2007, 16(2):186-187.
[32]	李镇利, 杨田. 黄色肉芽肿性胆囊炎的诊断和外科治疗[J]. 临床肝胆病杂志, 2017, 33(2):247-252.
[33]	Kwon AH, Matsui Y, Uemura Y. Surgical procedures and histopathologic findings for patients with xanthogranulomatous cholecystitis[J]. J Am Coll Surg, 2004, 199(2):204-210. doi:10.1016/j.jamcollsurg.2004.03.018 URL
[34]	王蔚蓝, 孙海明. 黄色肉芽肿性胆囊炎45例诊治分析[J]. 肝胆胰外科杂志, 2015, 27(1):74-75.
[35]	孙备, 周一男. 腹腔镜胆囊癌根治术的适应证及临床价值[J]. 中国普外基础与临床杂志, 2012, 19(4):364-367.
[1]	Christensen AH, Ishak KG. Benign tumors and pseudotumors of the gallbladder. report of 180 cases[J]. Arch Pathol, 1970, 90(5):423-432.
[2]	McCoy JJ Jr, Vila R, Petrossian G, et al. Xanthogranulomatous cholecystitis. report of two cases[J]. J S C Med Assoc, 1976, 72(3):78-79. pmid:1063276
[3]	Guzmán-Valdivia G. Xanthogranulomatous cholecystitis: 15 years′ experience[J]. World J Surg, 2004, 28(3):254-257. pmid:14961199
[4]	张弢, 王明亮, 臧潞, 等. 黄色肉芽肿性胆囊炎74例诊治分析[J]. 中国实用外科杂志, 2007, 27(7):549-550.
[5]	Yucel O, Uzun MA, Tilki M, et al. Xanthogranulomatous cholecystitis: analysis of 108 patients[J]. Indian J Surg, 2017, 79(6):510-514. doi:10.1007/s12262-016-1511-0 URL
[6]	Ewelukwa O, Ali O, Akram S. Xanthogranulomatous cholecystitis mimicking gallbladder cancer[J]. BMJ Case Rep, 2014:bcr2013200530.
[7]	Hale MD, Roberts KJ, Hodson J, et al. Xanthogranulomatous cholecystitis: a European and global perspective[J]. HPB (Oxford), 2014, 16(5):448-458. doi:10.1111/hpb.12152 URL
[8]	Kosar MN, Ongen A, Karakas BR, et al. Xanthogranulomatous cholecystitis: an analysis of 55 cases[J]. Eur Surg, 2014, 46(6):273-276. doi:10.1007/s10353-014-0289-1 URL
[9]	Han SH, Chen YL. Diagnosis and treatment of xanthogranulomatous cholecystitis: a report of 39 cases[J]. Cell Biochem Biophys, 2012, 64(2):131-135. doi:10.1007/s12013-012-9381-y URL
[10]	Ghosh M, Sakhuja P, Agarwal AK. Xanthogranulomatous cholecystitis: a premalignant condition?[J]. Hepatobiliary Pancreat Dis Int, 2011, 10(2):179-184. doi:10.1016/S1499-3872(11)60028-3 URL
[11]	Yabanoglu H, Aydogan C, Karakayali F, et al. Diagnosis and treatment of xanthogranulomatous cholecystitis[J]. Eur Rev Med Pharmacol Sci, 2014, 18(8):1170-1175.
[12]	Nacif LS, Hessheimer AJ, Rodríguez Gómez S, et al. Infiltrative xanthogranulomatous cholecystitis mimicking aggressive gallbladder carcinoma: a diagnostic and therapeutic dilemma[J]. World J Gastroenterol, 2017, 23(48):8671-8678. doi:10.3748/wjg.v23.i48.8671 URL
[13]	Khan MR, Begum S. Extended resection for xanthogranulomatous cholecystitis mimicking gallbladder carcinoma: cases and review of diagnostic approach[J]. J Pak Med Assoc, 2019, 69(2):256-260.
[14]	Lee ES, Kim JH, Joo I, et al. Xanthogranulomatous cholecystitis: diagnostic performance of US, CT, and MRI for differentiation from gallbladder carcinoma[J]. Abdom Imaging, 2015, 40(7):2281-2292. doi:10.1007/s00261-015-0432-x URL
[15]	Park JW, Kim KH, Kim SJ, et al. Xanthogranulomatous cholecystitis: is an initial laparoscopic approach feasible?[J]. Surg Endosc, 2017, 31(12):5289-5294. doi:10.1007/s00464-017-5604-zpmid:28593410
[16]	Goshima S, Chang S, Wang JH, et al. Xanthogranulomatous cholecystitis: diagnostic performance of CT to diffe-rentiate from gallbladder cancer[J]. Eur J Radiol, 2010, 74(3):79-83.
[36]	张宗明, 张翀, 刘立民, 等. 胆囊癌转移与种植的防治现状[J]. 肿瘤综合治疗电子杂志, 2019, 5(4):28-31.
[17]	吴世勇, 胡苗苗, 李梅, 等. 黄色肉芽肿性胆囊炎的多层螺旋CT不典型征象[J]. 中国医学影像学杂志, 2019, 27(7):501-503.

黄色肉芽肿性胆囊炎的诊治

Diagnosis and treatment of xanthogranulomatous cholecystitis

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献17

相关文章15

编辑推荐

Metrics

本文评价

[1]	邢颖, 程石.胆囊癌新辅助治疗的现状和争议[J]. 外科理论与实践, 2023, 28(02): 110-114.
[2]	王远江, 邹浩.胆囊癌综合治疗的临床研究[J]. 外科理论与实践, 2023, 28(02): 171-176.
[3]	冯梅晶, 任新平.超声造影在胆囊隆起样病变诊断中的应用进展[J]. 诊断学理论与实践, 2023, 22(01): 68-74.
[4]	沈盛, 高志慧, 辛艳磊, 郑博豪, 刘厚宝, 锁涛.基于专科化发展的胆囊切除术经济学成本分析[J]. 外科理论与实践, 2022, 27(04): 334-339.
[5]	满高亚, 党同科, 吴清松, 冯飞灵.Rouviere沟引导胆囊后隧道解剖用于困难腹腔镜胆囊切除术[J]. 外科理论与实践, 2022, 27(03): 239-243.
[6]	陈炫武, 杨传玉, 蒋敏杰, 杜卫东.胆囊腺肌症的发病机制及诊治研究进展[J]. 外科理论与实践, 2022, 27(01): 87-90.
[7]	胡刚峰, 黄侠.LC联合ERCP一期治疗胆囊结石合并肝外胆管结石与分期ERCP+LC手术疗效比较[J]. 外科理论与实践, 2021, 26(05): 437-440.
[8]	冯林松, 朱海峰, 汪韬, 郁林海, 徐国权, 顾春飞, 褚永悦, 潘炳权, 钟诚.单孔腹腔镜胆囊切除术中胆道造影分析（附64例报告）[J]. 外科理论与实践, 2021, 26(05): 456-459.
[9]	吴钢, 蔡端.外科治疗胆囊息肉：争议与对策[J]. 外科理论与实践, 2021, 26(02): 107-110.
[10]	蔡晨, 龚伟.胆囊癌辅助治疗的研究进展[J]. 外科理论与实践, 2021, 26(02): 167-170.
[11]	吕田润, 李富宇.胆囊癌治疗可否迈入微创时代[J]. 外科理论与实践, 2021, 26(02): 174-178.
[12]	张诚, 杨玉龙.胆胰管汇合部疾病与胆囊切除术后综合征关系的认识[J]. 外科理论与实践, 2020, 25(06): 460-463.
[13]	蔡业冰, 陈拥军.胆囊癌伴脐部转移（附1例报告）[J]. 外科理论与实践, 2020, 25(06): 520-522.
[14]	张道建, 张德祥, 王吉文, 陆品相, 刘厚宝, 刘寒.声造影对胆囊癌与黄色肉芽肿性胆囊炎的鉴别诊断价值[J]. 外科理论与实践, 2020, 25(04): 322-325.
[15]	姚伟, 孔雷, 吴庆华, 陆一凡, 叶靳华, 赵良超, 徐敬慈, 李能平.早期腹部CT检查在制定急性胆源性胰腺炎诊疗方案中的作用[J]. 外科理论与实践, 2019, 24(03): 236-241.